CAH Cardinal Health
Data as of close
S&P 500 CompaniesDividend Aristocrats
Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cardinal Health (CAH) is an industrial company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $60.9 billion. Shares last traded at $261.98, near their 52-week high. Over the past year the stock is up 37.7%. CAH trades at a price-to-earnings ratio of 36.66, above the Wholesale-Drugs, Proprietaries & Druggists' Sundries median of 26.00. Net profit margin is 0.7%, below the peer median of 0.7%. Revenue grew 14.2% year over year. The shares yield 0.8% in dividends.
* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2025-12-31. Source: SEC EDGAR/XBRL.
CAH Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2026-06-30 | $491M | $2.07 | 29% |
| 2025-06-30 | $494M | $2.04 | 32% |
| 2024-06-30 | $499M | $2.02 | 59% |
| 2023-06-30 | $525M | $2.00 | 159% |
| 2022-06-30 | $559M | $2.00 | — |
| 2021-06-30 | $573M | $1.95 | 94% |
| 2020-06-30 | $569M | $1.94 | — |
| 2019-06-30 | $577M | $1.92 | 42% |
| 2018-06-30 | $581M | $1.84 | 227% |
| 2017-06-30 | $577M | $1.80 | 45% |
| 2016-06-30 | $512M | $1.55 | 36% |
| 2015-06-30 | $460M | $1.37 | 38% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
CAH is a Dividend Aristocrat (25+ consecutive years of increases). Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| FY 2026 | $7.23 | 2026-08-11 |
| Q1 2026 | $1.88 | 2025-10-30 |
| FY 2025 | $6.45 | 2025-08-12 |
| Q1 2025 | $1.70 | 2024-11-01 |
| Q4 2024 (derived) | $0.93 | 2024-08-14 |
| FY 2024 | $3.45 | 2024-08-14 |
Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.
Wholesale-Drugs, Proprietaries & Druggists' Sundries peers
CAH vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Data as of close
| MCK | McKesson Corporation | $123.4B | 26.26 | 0.29 | 1.1% | +6.85% |
| COR | Cencora | $67.6B | 25.74 | 0.20 | 0.8% | +3.84% |
| CAH | Cardinal Health | $60.9B | 36.66 | 0.25 | 0.7% | +3.57% |
| HLF | Herbalife Ltd. | $1.6B | 8.93 | 0.30 | 3.4% | +6.32% |
| NUS | NU SKIN ENTERPRISES, INC. | $243M | — | 0.18 | -15.7% | +6.40% |
| COSM | Cosmos Health Inc. | $33M | — | 0.45 | -33.1% | +8.79% |
| ESYN | HWH International Inc. | $13M | — | — | — | -1.49% |
| MEDS | DataMeds AI, Inc. | $5M | — | — | — | -16.11% |
| HKPD | Cellyan Biotechnology Co., Ltd | $2M | — | — | — | +2.76% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.